Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Swanson

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Immunology|February 11, 2020
Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF DomainsSteven D Levin, Lawrence S Evans, Susan Bort, et al.
Nanomedicine (London, England)|July 20, 2021
Zn-based physiometacomposite nanoparticles: distribution, tolerance, imaging, and antiviral and anticancer activityRobert K DeLong, Ryan Swanson, Megan C Niederwerder, et al.
Nature Communications|April 5, 2022
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunityMark F Maurer, Katherine E Lewis, Joseph L Kuijper, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
<i>De novo</i> design of ACE2 protein decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Science (New York, N.Y.)|November 6, 2020
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Immunology|February 11, 2020
Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF DomainsSteven D Levin, Lawrence S Evans, Susan Bort, et al.
Nanomedicine (London, England)|July 20, 2021
Zn-based physiometacomposite nanoparticles: distribution, tolerance, imaging, and antiviral and anticancer activityRobert K DeLong, Ryan Swanson, Megan C Niederwerder, et al.
Nature Communications|April 5, 2022
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunityMark F Maurer, Katherine E Lewis, Joseph L Kuijper, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
<i>De novo</i> design of ACE2 protein decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Science (New York, N.Y.)|November 6, 2020
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Pageof 2